semaglutide cancer cases GLP-1 medications may offer benefits beyond weight loss and diabetes management, including improved outcomes for breast patients who are obese or have type 2 diabetes, according to new research. The study For years, researchers have known

The FDA-approved labeling for tirzepatide states that pancreatitis has been observed in clinical trials

Measuring Progress Because the goal is body composition change rather than simple weight loss, relying solely on the scale can be misleading

Median T30 (time = 30 min after meal test) GLP-1 levels in the placebo group were 15.8 pg ml 1 (IQR 5.632.0) compared with 10.4 pg ml 1 (IQR 6.431.3) in the semaglutide group (Supplementary Fig

Did the escitalopram prevent a heart attack

A PCP will prescribe weight-loss medication when a patient meets medical eligibility criteria and lifestyle changes alone haven't yielded sufficient results